Dravya Discovery

According to World Health Organisation, at least 1 billion people are affected by vision impairment which can either be prevented or has yet to be addressed. 81% of visual impairment could be avoided if diagnosed or treated early (WHO statistics). Patients suffering from Ocular diseases are missing out on clinically meaningful solutions because of a lack of robust and fast drug discovery approach. At Dravya Discovery, our mission is to be a trusted pre-clinical research partner offering novel, translational and validated assays for Ophthalmology drug discovery. The Dravya Discovery team draws on over 10 years experience to help Ophthalmology discovery teams identify new drugs using our novel translational assays combined with digital tools to analyse, share and report data in a regulatory compliant way.